Q4 2024 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2025-02-14 · accession 0001013594-25-000268
$19.1M
Reported value
19
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $2.5M | 13.3% | 36,700 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $2.4M | 12.7% | 1,025,806 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $1.8M | 9.27% | 500,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $1.7M | 8.90% | 335,400 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.2M | 6.48% | 195,700 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.1M | 5.79% | 40,300 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $972,490 | 5.09% | 79,000 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS LTD | $907,902 | 4.75% | 45,900 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $847,845 | 4.44% | 22,700 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $783,060 | 4.10% | 62,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $727,100 | 3.81% | 55,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $684,160 | 3.58% | 32,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $672,640 | 3.52% | 64,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $672,040 | 3.52% | 10,600 | Common | SOLE |
| 09609G209 | BLE0 | BLUEBIRD BIO INC | $658,126 | 3.45% | 78,912 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $644,959 | 3.38% | 46,300 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $446,408 | 2.34% | 57,750 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $283,172 | 1.48% | 340,761 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $31,500 | 0.16% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.